Pulmatrix Inc.

PULM | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.68

+$0.24 (+16.67%)

At close: Sep 21, 2026, 4:00 PM ET

$1.79

+$0.11 (+6.55%)

Pre-market: Sep 22, 2026, 8:40 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+16.67%

(1D)

Rating

Updated: Aug 14, 2026

21.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $6.14M

1D Range

1.42 1.68

52W Range

1.16 5.50

Valuation (TTM)

PE -1.53

PB 2.40

EV/EBITDA -0.99

Valuation (NTM)

Forward PE 2.90

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -63.7%

SBC Adj. FCF Yield -64.0%

SBC Impact -0.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -145.3% | -32.1%

Dil EPS 3Y | 5Y 44.9% | 40.7%

FCF 3Y | 5Y 56.8% | 31.9%

Returns

ROA -123.6%

ROE -109.3%

ROIC -160.8%

Financial Health

Net Cash

$2.17M

Current Ratio 4.70

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respirat...

Sector Healthcare

Industry Biotechnology

Employees 2

IPO Date Mar 20, 2014

Website www.pulmatrix.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞